Statin therapy may attenuate the elevated MACE risk typically observed with tofacitinib vs TNF inhibitors among patients with RA and pre-existing ASCVD.
Symptomatic people with evidence of coronary artery disease on imaging significantly benefited from statin use while those ...
More than one in four patients in the United States with atherosclerotic cardiovascular disease (ASCVD) are not on a guideline-recommended statin or other lipid-lowering therapy, with suboptimal ...
Lifetime use of standard statin increased QALYs by 0.24 to 0.70, with further increase seen for higher-intensity statins. HealthDay News — Statin therapy improves health outcomes and is cost-effective ...
Health care professionals caution on the persistent/residual cardiovascular risk that remains in patients who have their LDL well controlled on statin therapy. Deepak L. Bhatt, MD, MPH: One thing that ...
Statin therapy demonstrated a dose-dependent increase in the risk for new-onset diabetes, especially among individuals already at high risk for diabetes. Higher doses of statin therapy moderately ...
ERIKA: JESSICA IS BACK WITH THE LOCAL RESEARCH, AND WHAT IT MEANS. JESSICA: YEAH, THAT’S RIGHT. AND THAT HESITANCY WAS EVEN MORE PRONOUNCED IN WOMEN. WE’RE TALKING ABOUT STATINS, A COMMON FAMILY OF ...
Please provide your email address to receive an email when new articles are posted on . Statin therapy may lower risk for stroke or transient ischemic attack among patients with atrial fibrillation.
Credit: Shutterstock. Small increases in the risk for statin-associated muscle symptoms were observed for patients on high-intensity therapy. While statins are known to cause musculoskeletal symptoms, ...
Taking a statin medication is an effective, safe, and low-cost way to lower cholesterol and reduce risk of cardiovascular events. Despite clinicians recommending that many patients with diabetes take ...
Please provide your email address to receive an email when new articles are posted on . Statin therapy was not associated with dementia, mild cognitive impairment and/or any of its subclassifications, ...
The use of statin therapy in adults 65 years old or older is not associated with incident dementia, mild cognitive impairment (MCI) or decline in individual cognition domains, according to a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback